{"id":70699,"date":"2026-05-12T09:19:23","date_gmt":"2026-05-12T09:19:23","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70699"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"selank","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/selank\/","title":{"rendered":"Selank"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es el Selank?<\/h3>\n<p style=\"margin: 0;\"><strong>Selank<\/strong> is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">129954-34-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">751.88 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH<sub>2<\/sub> (TKPRPGP-NH<sub>2<\/sub>, 7 amino\u00e1cidos; an\u00e1logo de tuftsina amidado en el extremo C)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (blanco a blanquecino)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar dentro de ~30 d\u00edas. Proteger de la luz. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es el Selank?<\/h2>\n<p><strong>Selank<\/strong> is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a>. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank&#8217;s well-characterised sequence is TKPRPGP-NH<sub>2<\/sub>, peso molecular 751,88 Da, f\u00f3rmula emp\u00edrica C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> p\u00e1gina de producto. <\/p>\n<h2>Mecanismo de Acci\u00f3n \u2014 V\u00edas GABA\u00e9rgica, Serotonin\u00e9rgica y de BDNF<\/h2>\n<p>What makes Selank distinctive among anxiolytic compounds is its <strong>perfil de neuromodulaci\u00f3n multipathway<\/strong> sin uni\u00f3n directa a receptores en el sitio de las benzodiazepinas del GABA<sub>A<\/sub> benzodiazepine site \u2014 each contributing to the observed anxiolytic and nootropic phenotype in published studies:<\/p>\n<ul>\n<li><strong>Modulaci\u00f3n GABA\u00e9rgica sin uni\u00f3n al sitio de las benzodiazepinas<\/strong> \u2014 Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank&#8217;s pharmacology.<\/li>\n<li><strong>Se\u00f1alizaci\u00f3n serotonin\u00e9rgica y encefalin\u00e9rgica<\/strong> \u2014 Published studies has documented increased serotonin metabolism (5-HIAA \/ 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.<\/li>\n<li><strong>Expresi\u00f3n de BDNF y neuroplasticidad<\/strong> \u2014 Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank&#8217;s nootropic profile \u2014 improved memory consolidation and learning performance in rodent maze tasks.<\/li>\n<\/ul>\n<p>Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Selank is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Farmacolog\u00eda ansiol\u00edtica<\/strong> \u2014 pruebas de laberinto elevado m\u00e1s, campo abierto e interacci\u00f3n social en modelos de roedores de ansiedad generalizada; brazos comparativos frente a benzodiazepinas (diazepam) e ISRS (Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)<\/li>\n<li><strong>Stress resilience and HPA-axis studies<\/strong> \u2014 modelos de estr\u00e9s cr\u00f3nico leve, estr\u00e9s por restricci\u00f3n y desamparo aprendido; din\u00e1mica del cortisol y la ACTH<\/li>\n<li><strong>BDNF and neuroplasticity studies<\/strong> \u2014 expresi\u00f3n de BDNF en hipocampo y corteza prefrontal, morfolog\u00eda de espinas dendr\u00edticas, electrofisiolog\u00eda de potenciaci\u00f3n a largo plazo<\/li>\n<li><strong>Cognitive and memory studies<\/strong> \u2014 laberinto acu\u00e1tico de Morris, reconocimiento de objetos nuevos, evitaci\u00f3n pasiva; efectos nootr\u00f3picos independientes de la ansiolisis<\/li>\n<li><strong>Inmunomodulaci\u00f3n<\/strong> \u2014 Selank inherits tuftsin&#8217;s immunomodulatory activity, with documented effects on cytokine balance (TNF-\u03b1, IL-6, IFN-\u03b3) and macrophage function in published studies<\/li>\n<li><strong>Comparative studies vs benzodiazepines<\/strong> \u2014 comparaci\u00f3n directa con diazepam, alprazolam y fenazepam en eficacia ansiol\u00edtica, potencial de dependencia y efecto rebote; el perfil de abstinencia limpio de Selank es uno de los hallazgos m\u00e1s citados en la literatura rusa<\/li>\n<li><strong>Sister-peptide studies<\/strong> \u2014 evaluaci\u00f3n comparativa frente a <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.<\/li>\n<\/ul>\n<p>For broader context on small-peptide neuromodulation and nootropic studies, see <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> como el comparador nootr\u00f3pico can\u00f3nico desarrollado en Rusia, <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> for the parallel small-peptide healing-compound. Browse the full <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para compuestos relacionados. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, intranasal-vehicle formulation studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols. <\/p>\n<h2>Comparativa: Selank vs Semax<\/h2>\n<p>Selank y <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic\/neuroprotective. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Semax<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longitud<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (heptap\u00e9ptido)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (heptap\u00e9ptido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>P\u00e9ptido progenitor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tuftsina (TKPR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fragmento de ACTH(4-10)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Modulaci\u00f3n GABA, BDNF, encefalina<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BDNF, receptores de melanocortina, dopamina<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico, resiliencia al estr\u00e9s<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootr\u00f3pico, neuroprotector, concentraci\u00f3n<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 mcg\/d\u00eda<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u20131.000 mcg\/d\u00eda<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico en Rusia<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico aprobado (intranasal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootr\u00f3pico\/aprobado para recuperaci\u00f3n de ictus (intranasal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stacking in studies<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frecuentemente combinado con Semax para efecto ansiol\u00edtico+nootr\u00f3pico complementario<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frecuentemente combinado con Selank<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because the two peptides act on complementary axes \u2014 Selank on GABA\/anxiolytic, Semax on melanocortin\/dopaminergic\/nootropic \u2014 they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original para stock de trabajo a corto plazo. Para almacenamiento a largo plazo sin abrir, congele a \u221220 \u00b0C. El Selank liofilizado es estable en refrigeraci\u00f3n hasta 24 meses y a \u221220 \u00b0C hasta 36 meses. Evite ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo liofilizado. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 1.0\u00a0mL of bacteriostatic water yields a 5\u00a0mg\/mL working concentration; 0.1\u00a0mL delivers a 500\u00a0mcg dose. Swirl gently \u2014 do <strong>ajuste<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> almacene refrigerado a 2\u20138 \u00b0C y util\u00edcelo dentro de los 30 d\u00edas para una estabilidad \u00f3ptima. No congele la soluci\u00f3n reconstituida: los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan la integridad del p\u00e9ptido. Deseche cualquier vial que muestre turbidez, precipitado o decoloraci\u00f3n. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is Selank used for in studies?<\/h3>\n<p>Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is <strong>ajuste<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>\u00bfEn qu\u00e9 se diferencia Selank de Semax?<\/h3>\n<p>Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways \u2014 canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation \u2014 canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping. <\/p>\n<h3>What is the typical Selank dose?<\/h3>\n<p>Published Russian protocols typically use 300\u2013900\u00a0mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5\u00a0mg vial reconstituted with 1.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 0.1\u00a0mL equals 500\u00a0mcg, a typical single-dose studies aliquot. <\/p>\n<h3>\u00bfEst\u00e1 Selank aprobado por la FDA?<\/h3>\n<p>No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez). <\/p>\n<h3>\u00bfC\u00f3mo debe almacenarse Selank?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138 \u00b0C para existencias de trabajo a corto plazo, o \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Soluci\u00f3n reconstituida: refrigerada a 2\u20138 \u00b0C, usar dentro de los 30 d\u00edas. No congele la soluci\u00f3n reconstituida: los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan el p\u00e9ptido. Proteja de la luz directa en todo momento. <\/p>\n<h3>\u00bfC\u00f3mo reconstituyo Selank?<\/h3>\n<p>Siga el procedimiento de reconstituci\u00f3n anterior. A\u00f1ada agua bacteriost\u00e1tica por la pared lateral del vial (no sobre el polvo liofilizado), agite suavemente y permita de 2 a 5 minutos para la disoluci\u00f3n completa. No <strong>ajuste<\/strong> agite el vial. Una soluci\u00f3n correctamente reconstituida es clara e incolora. Para un vial de 5 mg + 1,0 mL de diluyente, la concentraci\u00f3n de trabajo es de 5 mg\/mL. <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase carries Selank in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Selank be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models. <\/p>\n<h3>Can Selank and Semax be stacked in studies?<\/h3>\n<p>Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA\/enkephalin\/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin\/dopaminergic\/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress. <\/p>\n<h3>Does Selank cause side reported effects?<\/h3>\n<p>Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation \u2014 in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media del Selank?<\/h3>\n<p>In preclinical studies, Selank has an estimated plasma half-life of approximately 15\u201330 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance. <\/p>\n<h3>How long does Selank take to show effects in preclinical studies?<\/h3>\n<p>Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30\u201360 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7\u201314 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models. <\/p>\n<h3>\u00bfPuedo pedir Selank para env\u00edo internacional?<\/h3>\n<p>S\u00ed. MedsBase env\u00eda Selank a todo el mundo desde nuestra red dedicada de env\u00edo de p\u00e9ptidos. Los pedidos que contienen solo p\u00e9ptidos califican para nuestro servicio de env\u00edo independiente de p\u00e9ptidos. Todos los pedidos se env\u00edan en embalajes con control de temperatura con seguimiento completo y est\u00e1n cubiertos por nuestro <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies<\/h2>\n<ul>\n<li><a href=\"\/es\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Sister heptapeptide from the same Russian clinical \u2014 nootropic and neuroprotective studies<\/li>\n<li><a href=\"\/es\/epitalon\/\"><strong>Epital\u00f3n<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<li><a href=\"\/es\/kpv-lysine-proline-valine\/\"><strong>KPV<\/strong><\/a> \u2014 Small immunomodulatory tripeptide \u2014 inflammation and barrier studies<\/li>\n<li><a href=\"\/es\/adamax\/\"><strong>Adamax<\/strong><\/a> \u2014 Heptapeptide nootropic compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore small-peptide nootropic studies<\/strong><\/p>\n<p style=\"margin: 0;\">Explora toda la <a href=\"https:\/\/medsbase.com\/es\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, con compuestos relacionados que incluyen <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> for melanocortin-axis nootropic studies, <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/es\/adamax\/\">Adamax<\/a> for sister heptapeptide cognitive studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Ansiol\u00edtico sin sedaci\u00f3n<br \/>\n\u2705 Modulaci\u00f3n multipathway GABA\/BDNF\/encefalina<br \/>\n\u2705 Stress-resilience compound<br \/>\n\u2705 P\u00e9ptido biodisponible por v\u00eda intranasal<br \/>\n\u2705 Perfil de abstinencia limpio vs benzodiacepinas<\/p>\n<p><strong>Selank<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70977,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,6273],"class_list":["post-70699","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-selank","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/70699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=70699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70977"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=70699"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=70699"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=70699"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=70699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}